BACKGROUND: Despite the increasing use of Roux-en-Y gastric bypass (RYGBP) in the treatment of morbid obesity, data about postoperative nutritional deficiencies and their treatment remain scarce. OBJECTIVE: The aim of this study was to evaluate the efficacy of a standard multivitamin preparation in the prevention and treatment of nutritional deficiencies in obese patients after RYGBP. DESIGN: This was a retrospective study of 2 y of follow-up of obese patients after RYGBP surgery. Between the first and the sixth postoperative months, a standardized multivitamin preparation was prescribed for all patients. Specific requirements for additional substitutive treatments were systematically assessed by a biologic workup at 3, 6, 9, 12, 18, and 24 mo. RESULTS: A total of 137 morbidly obese patients (110 women and 27 men) were included. The mean (+/-SD) age at the time of surgery was 39.9 +/- 10.0 y, and the body mass index (in kg/m(2)) was 46.7 +/- 6.5. Three months after RYGBP, 34% of these patients required at least one specific supplement in addition to the multivitamin preparation. At 6 and 24 mo, this proportion increased to 59% and 98%, respectively. Two years after RYGBP, a mean amount of 2.9 +/- 1.4 specific supplements had been prescribed for each patient, including vitamin B-12, iron, calcium + vitamin D, and folic acid. At that time, the mean monthly cost of the substitutive treatment was $34.83. CONCLUSION: Nutritional deficiencies are very common after RYGBP and occur despite supplementation with the standard multivitamin preparation. Therefore, careful postoperative follow-up is indicated to detect and treat those deficiencies.
BACKGROUND: Despite the increasing use of Roux-en-Y gastric bypass (RYGBP) in the treatment of morbid obesity, data about postoperative nutritional deficiencies and their treatment remain scarce. OBJECTIVE: The aim of this study was to evaluate the efficacy of a standard multivitamin preparation in the prevention and treatment of nutritional deficiencies in obesepatients after RYGBP. DESIGN: This was a retrospective study of 2 y of follow-up of obesepatients after RYGBP surgery. Between the first and the sixth postoperative months, a standardized multivitamin preparation was prescribed for all patients. Specific requirements for additional substitutive treatments were systematically assessed by a biologic workup at 3, 6, 9, 12, 18, and 24 mo. RESULTS: A total of 137 morbidly obesepatients (110 women and 27 men) were included. The mean (+/-SD) age at the time of surgery was 39.9 +/- 10.0 y, and the body mass index (in kg/m(2)) was 46.7 +/- 6.5. Three months after RYGBP, 34% of these patients required at least one specific supplement in addition to the multivitamin preparation. At 6 and 24 mo, this proportion increased to 59% and 98%, respectively. Two years after RYGBP, a mean amount of 2.9 +/- 1.4 specific supplements had been prescribed for each patient, including vitamin B-12, iron, calcium + vitamin D, and folic acid. At that time, the mean monthly cost of the substitutive treatment was $34.83. CONCLUSION:Nutritional deficiencies are very common after RYGBP and occur despite supplementation with the standard multivitamin preparation. Therefore, careful postoperative follow-up is indicated to detect and treat those deficiencies.
Authors: Cheryl L Rock; Jennifer A Emond; Shirley W Flatt; Dennis D Heath; Njeri Karanja; Bilge Pakiz; Nancy E Sherwood; Cynthia A Thomson Journal: Obesity (Silver Spring) Date: 2012-03-08 Impact factor: 5.002
Authors: Antje Damms-Machado; Asja Friedrich; Klaus Michael Kramer; Katrin Stingel; Tobias Meile; Markus A Küper; Alfred Königsrainer; Stephan C Bischoff Journal: Obes Surg Date: 2012-06 Impact factor: 4.129
Authors: Kamal K Mahawar; Alastair Reid; Yitka Graham; Lindes Callejas-Diaz; Chetan Parmar; William Rj Carr; Neil Jennings; Rishi Singhal; Peter K Small Journal: Obes Surg Date: 2018-07 Impact factor: 4.129
Authors: Adrian T Billeter; Pascal Probst; Lars Fischer; Jonas Senft; Hannes G Kenngott; Thilo Schulte; Gabriella Clemens; Ulrike Zech; Markus W Büchler; Peter P Nawroth; Beat P Müller-Stich Journal: Obes Surg Date: 2015-11 Impact factor: 4.129
Authors: Lingtak-Neander Chan; Charlotte H Neilson; Elizabeth A Kirk; Tiana F Colovos; Diane R Javelli; Saurabh Khandelwal Journal: Obes Surg Date: 2015-12 Impact factor: 4.129
Authors: D Hofsø; N Nordstrand; L K Johnson; T I Karlsen; H Hager; T Jenssen; J Bollerslev; K Godang; R Sandbu; J Røislien; J Hjelmesaeth Journal: Eur J Endocrinol Date: 2010-08-26 Impact factor: 6.664